1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Type (2022-2028)
1.2.2 Phase-I
1.2.3 Phase-II
1.2.4 Phase-III
1.3 Market by Application
1.3.1 Global AI-based Clinical Trials Solution Provider Market Share by Application (2022-2028)
1.3.2 Pharmaceutical Companies
1.3.3 Academia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global AI-based Clinical Trials Solution Provider Market Size
2.2 AI-based Clinical Trials Solution Provider Market Size by Regions
2.2.1 AI-based Clinical Trials Solution Provider Growth Rate by Regions (2022-2028)
2.2.2 AI-based Clinical Trials Solution Provider Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 AI-based Clinical Trials Solution Provider Revenue by Players (2022 & 2028)
3.2 AI-based Clinical Trials Solution Provider Key Players Headquarters and Area Served
3.3 Key Players AI-based Clinical Trials Solution Provider Product/Solution/Service
3.4 Date of Enter into AI-based Clinical Trials Solution Provider Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global AI-based Clinical Trials Solution Provider Market Size by Type (2022-2028)
4.2 Global AI-based Clinical Trials Solution Provider Market Size by Application (2022-2028)
5 North America
5.1 North America AI-based Clinical Trials Solution Provider Market Forecast (2022-2028)
5.2 AI-based Clinical Trials Solution Provider Key Players in North America
5.3 North America AI-based Clinical Trials Solution Provider Market Size by Type
5.4 North America AI-based Clinical Trials Solution Provider Market Size by Application
6 Europe
6.1 Europe AI-based Clinical Trials Solution Provider Market Forecast (2022-2028)
6.2 AI-based Clinical Trials Solution Provider Key Players in Europe
6.3 Europe AI-based Clinical Trials Solution Provider Market Size by Type
6.4 Europe AI-based Clinical Trials Solution Provider Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific AI-based Clinical Trials Solution Provider Market Forecast (2022-2028)
7.2 AI-based Clinical Trials Solution Provider Key Players in Asia-Pacific
7.3 Asia-Pacific AI-based Clinical Trials Solution Provider Market Size by Type
7.4 Asia-Pacific AI-based Clinical Trials Solution Provider Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America AI-based Clinical Trials Solution Provider Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa AI-based Clinical Trials Solution Provider Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Unlearn.AI, Inc.
9.1.1 Unlearn.AI, Inc. Company Details
9.1.2 Unlearn.AI, Inc. Description and Business Overview
9.1.3 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Introduction
9.1.4 Unlearn.AI, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.1.5 Unlearn.AI, Inc. Recent Development
9.2 Saama Technologies
9.2.1 Saama Technologies Company Details
9.2.2 Saama Technologies Description and Business Overview
9.2.3 Saama Technologies AI-based Clinical Trials Solution Provider Introduction
9.2.4 Saama Technologies Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.2.5 Saama Technologies Recent Development
9.3 Antidote Technologies, Inc.
9.3.1 Antidote Technologies, Inc. Company Details
9.3.2 Antidote Technologies, Inc. Description and Business Overview
9.3.3 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Introduction
9.3.4 Antidote Technologies, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.3.5 Antidote Technologies, Inc. Recent Development
9.4 Phesi
9.4.1 Phesi Company Details
9.4.2 Phesi Description and Business Overview
9.4.3 Phesi AI-based Clinical Trials Solution Provider Introduction
9.4.4 Phesi Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.4.5 Phesi Recent Development
9.5 Deep 6 AI
9.5.1 Deep 6 AI Company Details
9.5.2 Deep 6 AI Description and Business Overview
9.5.3 Deep 6 AI AI-based Clinical Trials Solution Provider Introduction
9.5.4 Deep 6 AI Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.5.5 Deep 6 AI Recent Development
9.6 Innoplexus
9.6.1 Innoplexus Company Details
9.6.2 Innoplexus Description and Business Overview
9.6.3 Innoplexus AI-based Clinical Trials Solution Provider Introduction
9.6.4 Innoplexus Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.6.5 Innoplexus Recent Development
9.7 Mendel.ai
9.7.1 Mendel.ai Company Details
9.7.2 Mendel.ai Description and Business Overview
9.7.3 Mendel.ai AI-based Clinical Trials Solution Provider Introduction
9.7.4 Mendel.ai Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.7.5 Mendel.ai Recent Development
9.8 Intelligencia
9.8.1 Intelligencia Company Details
9.8.2 Intelligencia Description and Business Overview
9.8.3 Intelligencia AI-based Clinical Trials Solution Provider Introduction
9.8.4 Intelligencia Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.8.5 Intelligencia Recent Development
9.9 Median Technologies
9.9.1 Median Technologies Company Details
9.9.2 Median Technologies Description and Business Overview
9.9.3 Median Technologies AI-based Clinical Trials Solution Provider Introduction
9.9.4 Median Technologies Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.9.5 Median Technologies Recent Development
9.10 Symphony AI
9.10.1 Symphony AI Company Details
9.10.2 Symphony AI Description and Business Overview
9.10.3 Symphony AI AI-based Clinical Trials Solution Provider Introduction
9.10.4 Symphony AI Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.10.5 Symphony AI Recent Development
9.11 BioAge Labs, Inc.
9.11.1 BioAge Labs, Inc. Company Details
9.11.2 BioAge Labs, Inc. Description and Business Overview
9.11.3 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Introduction
9.11.4 BioAge Labs, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.11.5 BioAge Labs, Inc. Recent Development
9.12 AiCure, LLC
9.12.1 AiCure, LLC Company Details
9.12.2 AiCure, LLC Description and Business Overview
9.12.3 AiCure, LLC AI-based Clinical Trials Solution Provider Introduction
9.12.4 AiCure, LLC Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.12.5 AiCure, LLC Recent Development
9.13 CONSILX
9.13.1 CONSILX Company Details
9.13.2 CONSILX Description and Business Overview
9.13.3 CONSILX AI-based Clinical Trials Solution Provider Introduction
9.13.4 CONSILX Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.13.5 CONSILX Recent Development
9.14 DEEP LENS AI
9.14.1 DEEP LENS AI Company Details
9.14.2 DEEP LENS AI Description and Business Overview
9.14.3 DEEP LENS AI AI-based Clinical Trials Solution Provider Introduction
9.14.4 DEEP LENS AI Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.14.5 DEEP LENS AI Recent Development
9.15 Halo Health Systems
9.15.1 Halo Health Systems Company Details
9.15.2 Halo Health Systems Description and Business Overview
9.15.3 Halo Health Systems AI-based Clinical Trials Solution Provider Introduction
9.15.4 Halo Health Systems Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.15.5 Halo Health Systems Recent Development
9.16 Pharmaseal
9.16.1 Company Details
9.16.2 Pharmaseal Description and Business Overview
9.16.3 Pharmaseal AI-based Clinical Trials Solution Provider Introduction
9.16.4 Pharmaseal Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.16.5 Pharmaseal Recent Development
9.17 Ardigen
9.17.1 Ardigen Company Details
9.17.2 Ardigen Description and Business Overview
9.17.3 Ardigen AI-based Clinical Trials Solution Provider Introduction
9.17.4 Ardigen Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.17.5 Ardigen Recent Development
9.18 Trials.Ai
9.18.1 Trials.Ai Company Details
9.18.2 Trials.Ai Description and Business Overview
9.18.3 Trials.Ai AI-based Clinical Trials Solution Provider Introduction
9.18.4 Trials.Ai Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.18.5 Trials.Ai Recent Development
9.19 Koneksa Health
9.19.1 Koneksa Health Company Details
9.19.2 Koneksa Health Description and Business Overview
9.19.3 Koneksa Health AI-based Clinical Trials Solution Provider Introduction
9.19.4 Koneksa Health Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.19.5 Koneksa Health Recent Development
9.20 Euretos
9.20.1 Euretos Company Details
9.20.2 Euretos Description and Business Overview
9.20.3 Euretos AI-based Clinical Trials Solution Provider Introduction
9.20.4 Euretos Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.20.5 Euretos Recent Development
9.21 BioSymetrics
9.21.1 BioSymetrics Company Details
9.21.2 BioSymetrics Description and Business Overview
9.21.3 BioSymetrics AI-based Clinical Trials Solution Provider Introduction
9.21.4 BioSymetrics Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.21.5 BioSymetrics Recent Development
9.22 Google- Verily
9.22.1 Google- Verily Company Details
9.22.2 Google- Verily Description and Business Overview
9.22.3 Google- Verily AI-based Clinical Trials Solution Provider Introduction
9.22.4 Google- Verily Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.22.5 Google- Verily Recent Development
9.23 GNS Healthcare
9.23.1 GNS Healthcare Company Details
9.23.2 GNS Healthcare Description and Business Overview
9.23.3 GNS Healthcare AI-based Clinical Trials Solution Provider Introduction
9.23.4 GNS Healthcare Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.23.5 GNS Healthcare Recent Development
9.24 IBM Watson
9.24.1 IBM Watson Company Details
9.24.2 IBM Watson Description and Business Overview
9.24.3 IBM Watson AI-based Clinical Trials Solution Provider Introduction
9.24.4 IBM Watson Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.24.5 IBM Watson Recent Development
9.25 Exscientia
9.25.1 Exscientia Company Details
9.25.2 Exscientia Description and Business Overview
9.25.3 Exscientia AI-based Clinical Trials Solution Provider Introduction
9.25.4 Exscientia Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.25.5 Exscientia Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
